Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Aldabayan (London, United Kingdom), A. Al Rajah (London, United Kingdom), A. Aldhahir (London, United Kingdom), A. Lemson (Nijmegen , Netherlands), G. Nava (London, United Kingdom), J. Brown (London, United Kingdom), J. Hurst (London, United Kingdom). Cardiovascular risk and exercise capacity in COPD. 3639

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular limitation to exercise in COPD patients Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Cardiovascular risk detection in COPD Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Cardiovascular evaluation of tiotropium during constant-work rate exercise in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 49s Year: 2003 Determinants of exercise capacity in patients with COPD Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Determinants of exercise capacity in patients with COPD without other comorbidities Source: Annual Congress 2012 - Exercise capacity: from elite athletes to severe impairment Year: 2012 Self-reported cardiovascular disease and exercise performance in stable COPD Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance Year: 2009 Predictive factors of exercise capacity decline in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Assessment of exercise capacity in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 294s Year: 2004 Association of heart rate recovery after exercise test with exercise capacity in patients with stable COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Determinants of rapid exercise capacity decline in patients with COPD Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Exercise ventilatory inefficiency is an independent predictor of mortality in COPD Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease Year: 2015 Pulmonary rehabilitation affects lung hyperinflation and cardiovascular response to exercise in COPD Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Metabolic risk factors in patients with advanced COPD and the response to short-term high-intensity pulmonary rehabilitation Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases Year: 2015 Adrenomedullin independently predicts exertional hypoxemia in COPD – Results of European PROMISE COPD study Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Cardiovascular disease in COPD Source: Eur Respir Monogr 2020; 88: 47-65 Year: 2020 Stroke volume response and exercise capacity in COPD with and without pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 641s Year: 2006 Aerobic exercise capacity in COPD patients with and without pulmonary hypertension Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Physiological determinants of reduced tolerance to interval exercise in moderate-to-severe COPD Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease Year: 2016 Effect of ventilatory inefficiency over exercise capacity in COPD patients with hyperinflation Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015